The irritable bowel syndrome in mental patients

被引:0
|
作者
Kolesnikov, DB [1 ]
机构
[1] IM Sechenov Med Acad, Cardiol Clin, Moscow, Russia
[2] Russian Acad Med Sci, Mental Hlth Res Ctr, Dept Frontier Psychol Pathol & Psychosomat Disord, Moscow 109801, Russia
[3] Russian Acad Med Sci, Chronobiol & Gastroenterol Clin Problem Lab, Moscow, Russia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
140 patients with the irritable bowel syndrome were examined. According to the results of clinical analysis of the manifestations, symptomatology and structure of comorbidity, two syndrome types were identified. These included those: with the phenomena of autonomic or conversive neurosis (89,3 and 10,7% respectively). The syndrome with signs autonomic neurosis were characterized by: 1) spontaneous or somatogenic manifestation; 2) homomorphism and stability of both abdominalgias and defecation disorders; 3) limitation of functional disorders in gastrointestinal organs; 4) syndromal and temporary (parallelism of formation and dynamics) comorbidity with endogenous diseases (66%) (cyclothymia, slowly progressive schizophrenia), hypochondriac development (16%) and anxious-phobic disorders (18%); 5) correlation with subclinic somatic pathology of gastrointestinal tract. Syndrome with the phenomena of conversive neurosis was characterized by: 1) psychogenically induced manifestation; 2) polymorphism and instability of abdomnalgias and stool disorders; 3) polymorphism of functional disorders of different organ systems; 4) syndromic and temporary (parallelism of formation and dynamics) comorbidity with subsyndromic psychic disorders: transitent hysterohypochondriac phobias (cardiophobia, tanatophobia) - 60%, transitent (less than 2-3 months) hysteroaffective reactions caused by situations - 40%; 5) none or minimal concomitant subclinical gastrointestinal pathology.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 50 条
  • [41] Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review
    Glabska, Dominika
    Kolota, Aleksandra
    Lachowicz, Katarzyna
    Skolmowska, Dominika
    Stachon, Malgorzata
    Guzek, Dominika
    [J]. NUTRIENTS, 2021, 13 (10)
  • [42] Rifaximin in treatment of patients with Irritable bowel syndrome
    Romana, Bhupinder
    Tahan, Veysel
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 (01): : 77 - 78
  • [43] Psychiatric comorbidity in patients of Irritable Bowel Syndrome
    Chhiber, Sonakshi
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [44] Esophageal disorders in patients with irritable bowel syndrome
    Morozova, Yu N.
    Pogromov, A. P.
    Mnatsakanyan, M. G.
    Tashchyan, O., V
    Kolosova, K. Yu
    [J]. TERAPEVTICHESKII ARKHIV, 2020, 92 (02): : 19 - 23
  • [45] Allergic diseases in patients with irritable bowel syndrome
    Levchenko, A.
    Romaniuk, L.
    [J]. ALLERGY, 2020, 75 : 343 - 343
  • [46] Unmet needs of patients with irritable bowel syndrome
    不详
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (09): : 587 - 587
  • [47] Symptom duration in patients with irritable bowel syndrome
    Lembo, T
    Fullerton, S
    Diehl, D
    Raeen, H
    Munakata, J
    Naliboff, B
    Mayer, EA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (05): : 898 - 905
  • [48] Eating disorders in patients with irritable bowel syndrome
    Kayar, Yusuf
    Agin, Mehmet
    Dertli, Ramazan
    Kurtulmus, Ayse
    Boyraz, Rabia Keyser
    Onur, Nafiye Selcan
    Kirpinar, Ismet
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (10): : 607 - 613
  • [49] GYNECOLOGICAL CONSULTATION IN PATIENTS WITH THE IRRITABLE BOWEL SYNDROME
    PRIOR, A
    WHORWELL, PJ
    [J]. GUT, 1989, 30 (07) : 996 - 998
  • [50] Safety of Eluxadoline in Patients With Irritable Bowel Syndrome
    Croteau, Ryan
    Barkin, Jamie S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (10): : 1616 - 1616